By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

The Voice of People With Breast Cancer

Education

Our Voices Blog


Category : Knowledge

Breaking Barriers in Triple Negative Breast Cancer Care

If you’ve been with us for a while or if you have Triple Negative Breast Cancer (TNBC) you know that this subtype is considered more aggressive and has fewer treatment options than other subtypes of breast cancer. By now, you’re also likely aware of the risks associated with TNBC. In 2023, we launched a report that identifies the educational, informational, and support needs of Canadians diagnosed with TNBC. Since then, we’ve dedicated significant time to raising awareness about its findings, including targeted advocacy for improvements in key issues affecting TNBC patients or those who are at elevated risk of developing TNBC.

Finding Inclusive Resources for Your Unique Journey

We know that facing a breast cancer diagnosis is a daunting thing to experience. But for some, the challenges, fears, and uncertainty can be compounded by a lack of access to culturally competent care and tailored supportive resources that truly understand and address the unique needs of diverse community groups. We’ve compiled a non-exhaustive list of resources we know to be helpful and can provide much-needed assurance and support to culturally diverse communities, young women, those with high familial risk and LGBTQ+ individuals.

From Past to Present: Honoring Clinical Trials Day and Advancing Breast Cancer Care

Since 2014, May 20th has been promoted as Clinical Trials Day by the Association of Clinical Research Professionals. It is a moment to recognize the pivotal role clinical trials play in advancing research and treatment for many diseases, including breast cancer. This day was chosen to honour Scottish surgeon James Lind, who, in May 1747, conducted what is generally acknowledged as the first clinical trial.

Navigating persistent pain after breast cancer surgery: Challenges and solutions

Advances in the screening and management of breast cancer have resulted in substantial improvements for those diagnosed with the disease. Patients are living much longer after a breast cancer diagnosis, which is a major accomplishment of modern medicine. However, since patients are living longer, the complications associated with treatment (such as surgery, radiation, and chemotherapy) are becoming increasingly apparent. One such complication is the development of persistent pain in the area of breast cancer resection.

Prepectoral vs Subpectoral Implants

In the 1960s silicone gel breast implants came into use, allowing for breast reconstruction post-mastectomy or augmentation to be possible, but at that time, there was no clear standard for the implant placement. At first, surgeons placed the prosthesis in front of the chest (pectoralis major)  muscle, but the chance of postoperative complications was high.

Breast Cancer Screening: How the Provinces Stack Up

As Ontario plans to change the minimum age for screening in the fall to 40 from 50, we decided to break down the current breast screening criteria required by each province, as well as the planned changes.

Canada’s got pharmacare! Now what?

When the topic of national pharmacare made a resurgence in 2018, the Canadian Breast Cancer Network (CBCN) continued advocacy for an equitable and comprehensive approach to national prescription drug coverage. We have advocated that a national plan should provide Canadians with better access to life-saving medications than they currently have and improve equity of access nationally, so the newly announced legislation for a universal, single-payer, phased approach is a welcomed first step.

TNBC: Who’s at Risk?

Treatment can be difficult for this type of breast cancer. Without receptors, triple negative tumors do not have the proteins they need to respond to common breast cancer treatments like hormone and targeted therapy, which are used for hormone-positive or HER2-positive breast cancer. Research shows that some people have a greater chance of developing triple-negative breast cancer (TNBC) if they are subject to certain risk factors. 

Latest Research from SABCS 2023 – Metastatic

There was an abundance of promising new research that came out of the 2023 San Antonio Breast Cancer Symposium. Here are some highlights for metastatic breast cancer. Be sure to check out our early-stage highlights.

Latest Research from SABCS 2023 – Early Stage

CBCN had the pleasure of attending the San Antonio Breast Cancer Symposium in December. Below you’ll find the latest research for early-stage breast cancer. Watch out for the latest research on mBC.